(Q48732066)

15 February 2018

title

Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice (English)

1 reference

15 February 2018

1 reference

1 reference

Ajaykumar N Sharma

1

1 reference

15 February 2018

Khalid M Elased

series ordinal

2

1 reference

15 February 2018

James B Lucot

series ordinal

3

1 reference

15 February 2018

language of work or name

English

0 references

publication date

12 February 2012

1 reference

15 February 2018

Journal of Psychopharmacology

published in

1 reference

15 February 2018

volume

26

1 reference

15 February 2018

issue

5

1 reference

15 February 2018

page(s)

724-732

1 reference

15 February 2018

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Effects of short and long-lasting diabetes mellitus on mouse brain monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Treatment of mental illness at home by small doses of insulin; a follow-up report and appraisal of results in 26 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Hyperinsulinemia in pre-weaning diabetes (db) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Anxiety and depression symptoms in patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Alzheimer's disease is type 3 diabetes-evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

The role of dopamine in the pathophysiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Mesolimbic dopamine in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Cognition and synaptic plasticity in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

The consequences of anxious temperament for disease detection, self-management behavior, and quality of life in Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

The peroxisome proliferator activated receptor gamma (PPARgamma) ligand rosiglitazone modulates bronchoalveolar lavage levels of leptin, adiponectin, and inflammatory cytokines in lean and obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: no evidence for protective adaptation by the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

The relationship between posttraumatic stress disorder and self-reported health problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Prevention of diabetic nephropathy by diet control in the db/db mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Depression and poor glycemic control: a meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Is there savings for pavlovian fear conditioning after neurotoxic basolateral amygdala lesions in rats?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Neurobiology of Pavlovian fear conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Associations between posttraumatic stress disorder and hemoglobin A1(C) in low-income minority patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Diabetes mellitus in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Should we screen for emotional distress in type 2 diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Diabetes, obesity, and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Cerebrospinal fluid: identification of diagnostic markers for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Cardiovascular and autonomic phenotype of db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Neurobehavioral deficits in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Identification and expression cloning of a leptin receptor, OB-R

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Post-traumatic stress disorder and diabetes: co-morbidity and outcomes in a male veterans sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Hyperglycemia enhances excessive superoxide anion radical generation, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Metabotropic glutamate receptors: potential drug targets for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Leptin as a neuroactive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

Decreased glucose tolerance and plasma adiponectin:resistin ratio in a mouse model of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111434620

21 January 2018

Identifiers

DOI

10.1177/0269881111434620

1 reference

15 February 2018

1 reference

15 February 2018